2021-01-05,Alimera Sciences to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference
2020-12-24,Bristol Myers' (BMY) CNS Phase III Cancer Study on Opdivo Fails
2020-12-22,ChemoCentryx (CCXI) Reports Positive Top-Line Rare Disease Data
2020-12-21,Novo Nordisk (NVO) Files for Semaglutide Label Expansion in EU
2020-12-21,Berkeley Lights (BLI) in Focus: Stock Moves 6.3% Higher
2020-12-17,Aligos (ALGS) in Focus: Stock Moves 5.6% Higher
2020-12-16,Novartis' (NVS) Entresto Gets FDA Panel Nod for Expanded Use
2020-12-15,Roche (RHHBY) Gets FDA Nod for Shorter Infusion Time of Ocrevus
2020-12-14,Bristol Myers (BMY) Gets Positive CHMP Opinion for Inrebic
2020-12-11,"Alkermes (ALKS) Outlines Value Enhancement Plan, Shares Up"
2020-12-10,Ultragenyx (RARE) Gets Orphan Drug Tag for Wilson Disease Drug
2020-12-09,"Checkmate (CMPI), Bristol Myers Ink Deal for Cancer Combo"
2020-12-09,Alimera Sciences Announces Launch of ILUVIEN® in the Netherlands
2020-12-08,Chimerx's (CMRX) NDA for Brincidofovir Accepted by FDA
2020-12-08,Alimera Sciences to Present at the 13th Annual LD Micro Main Event Virtual Conference
2020-12-07,FDA Approves Label Expansion of Novo Nordisk's (NVO) Saxenda
2020-12-07,FDA Approves Label Expannsion of Novo Nordisk's (NVO) Saxenda
2020-12-04,Alnylam (ALNY) Ends Enrollment in Advanced Hyperoxaluria Study
2020-12-03,CytoDyn (CYDY) Enrolls First Patient in NASH Study on Leronlimab
2020-12-02,Do Hedge Funds Love Alimera Sciences Inc (ALIM)?
2020-12-02,Acceleron (XLRN) Gets Orphan Drug Tag for ACE-1334 by FDA
2020-12-02,Amicus (FOLD) Initiates Rolling BLA Submission for AT-GAA
2020-12-01,Verastem (VSTM) Begins Phase II Combo Study for Ovarian Cancer
2020-11-27,HorizonTherapeutics (HZNP) Rises YTD on Approvals & Buyouts
2020-11-24,Eiger (EIGR) Gets FDA Approval for Zokinvyin Rare Diseases
2020-11-20,Alnylam (ALNY) Gets EU Nod for Oxlumo to Treat Renal Disease
2020-11-18,Novo Nordisk's (NVO) Phase IIIb Study Meets Primary Endpoint
2020-11-16,"Alimera Sciences Announces Participation at the  11th Annual Craig-Hallum Alpha Select Conference on  Tuesday, November 17, 2020"
2020-11-13,Moderna (MRNA) Surges: Stock Moves 6.5% Higher
2020-11-12,Alimera Sciences Announces Real-World  Clinical Data for ILUVIEN® to be Presented at the  American Academy of Ophthalmology 2020 Virtual Conference
2020-11-09,Deciphera (DCPH) Reports Narrower-Than-Expected Loss in Q3
2020-11-06,"BioMarin (BMRN) Beats on Q3 Earnings, Lowers Sales View"
2020-11-06,"Global Blood (GBT) Q3 Loss Wider Than Expected, Sales Miss"
2020-11-06,"Amicus' (FOLD) Q3 Loss Wider Than Expected, Revenues Beat"
2020-11-05,Zoetis' (ZTS) Q3 Earnings and Revenues Surpass Estimates
2020-11-04,Alimera Sciences (ALIM) Upgraded to Buy: Here's Why
2020-10-30,Alimera Sciences Inc (ALIM) Q3 2020 Earnings Call Transcript
2020-10-30,"Earnings Release: Here's Why Analysts Cut Their Alimera Sciences, Inc. (NASDAQ:ALIM) Price Target To US$13.50"
2020-10-29,"Alimera Sciences, Inc. to Host Earnings Call"
2020-10-28,"Alimera Sciences (ALIM) Reports Q3 Loss, Tops Revenue Estimates"
2020-10-28,Alimera Sciences Announces Third Quarter 2020 Financial Results
2020-10-22,"Alimera Sciences to Report Third Quarter 2020 Financial Results on Wednesday, October 28, 2020 and Provide Corporate Update"
2020-09-23,Alimera Sciences Announces Multiple Posters and Papers  Highlighting the Durability of ILUVIEN® To Be Presented at the EURETINA 2020 Virtual Congress
2020-09-15,Alimera Sciences Signs Distribution Agreement  With Medis Pharmaceutical to Commercialize Iluvien®  in Austria and the Czech Republic
2020-09-09,"UPDATE -- Alimera Sciences Announces Participation at the H.C. Wainwright 22nd Annual Global Virtual Investment Conference on September 15, 2020"
2020-09-09,"Alimera Sciences Announces Participation at the H.C. Wainwright 22nd Annual Global Virtual Investment Conference on September 15, 2020"
2020-09-08,Alimera Sciences Obtains Reimbursement Approval for ILUVIEN® Use in Non-Infectious Posterior Uveitis in Scotland
2020-09-01,Spero's (SPRO) IND Accepted by FDA for Pulmonary Disease Drug
2020-09-01,Alimera Sciences Announces Enrollment of First Patient in Landmark NEW DAY Clinical Trial to Evaluate ILUVIEN® as Baseline Therapy for Diabetic Macular Edema
2020-08-31,LD Micro - 360 Companies Set to Present this Week
2020-08-30,"Who Has Been Buying Alimera Sciences, Inc. (NASDAQ:ALIM) Shares?"
2020-08-26,Alimera Sciences Announces National Reimbursement Granted for ILUVIEN® in the Netherlands
2020-08-25,"Alimera Sciences to Present at the LD Micro 500 Virtual Conference on September 2, 2020"
2020-08-13,Alimera Sciences Signs Distribution Agreement With Nordic Prime to Expand International Sales of ILUVIEN® Into Nordic Countries
2020-08-05,What Makes Alimera Sciences (ALIM) a New Strong Buy Stock
2020-08-05,New Strong Buy Stocks For August 5th
2020-08-05,LD Micro Announces Preliminary List of Presenters for the LD 500
2020-07-31,Alimera Sciences Inc (ALIM) Q2 2020 Earnings Call Transcript
2020-07-29,"Alimera Sciences (ALIM) Reports Q2 Loss, Tops Revenue Estimates"
2020-07-29,Recap: Alimera Sciences Q2 Earnings
2020-07-29,Alimera Sciences Announces Second Quarter 2020 Financial Results and Provides Corporate Update
2020-07-23,Alimera (ALIM) to Report Q2 Earnings: What's in the Cards?
2020-07-22,"Alimera Sciences to Report Second Quarter 2020 Financial Results on Wednesday, July 29, 2020 and Provide Corporate Update"
2020-07-09,Alimera Sciences Initiates Landmark NEW DAY Clinical Trial to Evaluate ILUVIEN&#174; as Baseline Therapy for Diabetic Macular Edema
2020-06-25,New Strong Buy Stocks For June 25th
2020-06-23,Edited Transcript of ALIM earnings conference call or presentation 30-Apr-20 1:00pm GMT
2020-06-16,New Strong Buy Stocks for June 16th
2020-06-10,Do Hedge Funds Love Alimera Sciences Inc (ALIM)?
2020-06-03,47 Public Companies to present at the Summer Virtual Investor Summit on June 9th-12th
2020-06-03,Alimera to Present at the June 2020 Virtual Summer Investor Summit
2020-04-30,Alimera Sciences Inc (ALIM) Q1 2020 Earnings Call Transcript
2020-04-29,"Alimera Sciences (ALIM) Reports Q1 Loss, Tops Revenue Estimates"
2020-04-29,Alimera Sciences Announces First Quarter 2020 Financial Results and Provides Corporate Update
2020-04-24,"Alimera Sciences to Report First Quarter 2020 Financial Results on Wednesday, April 29, 2020 and Provide Corporate Update"
2020-04-23,Alimera Sciences Receives $1.8 Million Loan Under the Paycheck Protection Act
2020-04-13,Alimera Sciences Pre-Announces Expected Top Line Revenue for Q1 2020 and Provides COVID-19 Business Update
2020-03-31,Penny Stocks to Buy Using Technical Analysis for April 2020
2020-03-31,"Alimera Sciences Appoints Steven T. Gill to the Newly Created Position of Vice President, Thought Leader Engagement"
2020-03-26,Edited Transcript of ALIM earnings conference call or presentation 27-Feb-20 2:00pm GMT
2020-03-25,Alimera Sciences Data Available for the 11th Annual Congress on Controversies in Ophthalmology: Europe Virtual Conference
2020-02-29,"Analysts Have Been Trimming Their Alimera Sciences, Inc. Price Target After Its Latest Report"
2020-02-26,Alimera Sciences (ALIM) Tops Q4 Earnings and Revenue Estimates
2020-02-26,Alimera Sciences Reports Record Fourth Quarter and 2019 Results
2020-02-24,Alimera Sciences Meets Revenue Milestone and Accesses Additional $2.5 Million Under Solar Debt Agreement
2020-02-20,"Alimera Sciences to Report Fourth Quarter and Full Year 2019 Financial Results on Wednesday, February 26, 2020 and Provide Corporate Update"
2020-01-29,"Insider Buying: The Alimera Sciences, Inc. (NASDAQ:ALIM)  Just Bought US$562k Worth Of Shares"
2020-01-27,"Alimera Sciences, Inc 13D/A filing"
2020-01-10,2 Healthcare Stocks Set to Rally into the New Year
2020-01-06,Alimera Sciences Refinances Its Debt Facility With Solar Capital
2019-12-17,Did Hedge Funds Drop The Ball On Alimera Sciences Inc (ALIM) ?
2019-12-11,"Almira Sciences, Inc 13D filing"
2019-12-04,"Alimera Sciences to Participate in the LD Micro 12th Annual Main Event on December 10, 2019"
2019-12-03,Alimera Announces Regulatory Approval for ILUVIEN® in Benelux Countries for The Treatment of Non-Infectious Posterior Uveitis
2019-11-26,Alimera Sciences to Participate in the 31st Annual Piper Jaffray Healthcare Conference
2019-11-20,Edited Transcript of ALIM earnings conference call or presentation 30-Oct-19 1:00pm GMT
2019-11-14,Alimera Sciences Announces Effectiveness of Previously Announced Reverse Stock Split
2019-11-13,Alimera Sciences Terminates Equity Purchase Agreement
2019-11-08,"The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera's Reverse Split, 2 Biotechs To Debut"
2019-11-07,Alimera Sciences Announces Boards Approval of Reverse Stock Split Ratio
2019-11-05,Alimera Sciences to Participate in the 10th Annual Craig-Hallum Alpha Select Conference in New York
